baclofen has been researched along with Leukomalacia, Periventricular in 1 studies
Leukomalacia, Periventricular: Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. (From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davanzo, JR | 1 |
| Rizk, E | 1 |
1 other study available for baclofen and Leukomalacia, Periventricular
| Article | Year |
|---|---|
Baclofen overdose from possible intrinsic malfunction of SynchroMed II pump.
Topics: Baclofen; Cerebral Palsy; Child; Device Removal; Drug Overdose; Equipment Failure; GABA-B Receptor A | 2015 |